Loncar Lyon Jenkins is now filing Xarelto side effects lawsuits in order to ensure victims of Xarelto excessive bleeding or blood clots receive due compensation
Xarelto (rivaroxaban), approved in 2011, is one of the newest anticoagulants (blood thinners) on the market. It is manufactured by Bayer and marketed by Johnson & Johnson subsidiary Janssen Pharmaceuticals. Xarelto was initially approved by the FDA for patients requiring hip replacement or knee surgery in order to prevent blood clots. Xarelto later received approval for general treatment of deep vein thrombosis (DVT) and pulmonary bleeding after an FDA fast-track regulatory review. Xarelto comes with a handful of side effects, most severely uncontrolled bleeding and hemorrhaging. It is common for other anticoagulant products such as Warfarin to maintain an antidote to the drug, but no such antidote exists for Xarelto. Once hemorrhaging occurs in a patient taking Xarelto, there is no effective way of stopping the bleeding and can sometimes result in death. A cumulative list of Xarelto side effects are as follows:
- Intestinal bleeding
- Thrombosis (blood clots)
- Decreased hemoglobin
- Cerebral hemorrhaging
- Hematoma (semisolid mass in the blood)
- Peripheral edema (swelling of the lower limbs)
- Dyspnea (difficulty breathing)
- Mycordial Infarction (heart attack)
- Hospitalization for excessive bleeding
If you or someone you know has experienced these health complications as a result of Xarelto, you may be eligible to file a Xarelto side effects lawsuit. Contact Loncar Lyon Jenkins immediately for a free, confidential case evaluation using the form or by calling toll free at 800.285.4878. We are currently filing suit for a large range of Xarelto damages, from death to blood transfusions. Xarelto side effects lawsuits are being evaluated on a contingency fee basis, meaning there are no out-of-pocket expenses to the client unless a recovery is obtained.
Pradaxa and Xarelto
Xarelto litigation is following on the heels of a $650 million Pradaxa settlement. Pradaxa is a similar blood thinning medication with no antidote, causing some patients to bleed to death. It is estimated that over 500 deaths are directly linked to the use of Pradaxa. Pradaxa and Xarelto are ranked among the FDA’s most dangerous drugs based on the number of adverse events reported. The similarities between Pradaxa and Xarelto point to a strong claim for those having suffered from severe Xarelto side effects.
Xarelto Side Effects Lawsuits
In the first eight months of 2013 there were a total of 968 cases of suspected undesirable side-effects related to Xarelto, including 72 cases of death. The amount of cases reported are expected to grow annually. The first Xarelto lawsuit was filed in June 2014 stating Bayer and Johnson & Johnson did not properly warn the public about the risks and should never have sold the drug. It is if our opinion that Bayer and Johnson & Johnson knew or should have known that Xarelto use was associated with irreversible bleeding, sometimes resulting in death. Had consumers been aware of the risks associated with Xarelto, they may have chosen an alternative anticoagulant with an antidote such as Warfarin. Xarelto wrongful death lawsuits can be filed by family members of patients who died of Xarelto complications. If you or somebody you know died or was injured while taking Xarelto, contact Loncar Lyon Jenkins immediately for a free, confidential case evaluation using the form on the side or by calling toll free at 800.285.4878.